New semi-synthetic penicillin active against Pseudomonas pyocyanea.
作者信息
Acred P, Brown D M, Knudsen E T, Rolinson G N, Sutherland R
出版信息
Nature. 1967 Jul 1;215(5096):25-30. doi: 10.1038/215025a0.
DOI:10.1038/215025a0
PMID:6069557
Abstract
摘要
相似文献
1
New semi-synthetic penicillin active against Pseudomonas pyocyanea.
Nature. 1967 Jul 1;215(5096):25-30. doi: 10.1038/215025a0.
2
Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.
Br Med J. 1967 Jul 8;3(5557):75-8. doi: 10.1136/bmj.3.5557.75.
3
[Carbenicillin effect on Pseudomonas pyocyanea].
Med Klin. 1969 Feb 14;64(7):284-7.
4
Toxicological studies on haloperidol.
Int J Neuropsychiatry. 1967 Aug;3:Suppl 1:19-21.
5
[General characteristics of polysynthetic penicillins].
Antibiotiki. 1971 Oct;16(10):870-7.
6
Carbenicillin, a new semisynthetic penicillin active against Pseudomonas aeruginosa.
Antimicrob Agents Chemother (Bethesda). 1967;7:609-13.
7
Absorption, distribution, biotransformation, and excretion of azidocillin, a new semi-synthetic penicillin, in mice, rats and dogs.
Arzneimittelforschung. 1972 Nov;22(11):1962-70.
8
[Semisynthetic penicillins with a chemical group with their own pharmacological activity].
Farmaco Sci. 1968 Nov;23(11):1097-103.
9
BL-P 1654, a new broad-spectrum penicillin with marked antipseudomonal activity.
Antimicrob Agents Chemother (Bethesda). 1970;10:17-29.
10
Pirbenicillin--a semi-synthetic penicillin with antipseudomonal activity.
J Antimicrob Chemother. 1977 Mar;3(2):175-83. doi: 10.1093/jac/3.2.175.
引用本文的文献
1
Functional characterization of bacteria isolated from ancient arctic soil exposes diverse resistance mechanisms to modern antibiotics.
PLoS One. 2015 Mar 25;10(3):e0069533. doi: 10.1371/journal.pone.0069533. eCollection 2015.
2
Crystal structures of penicillin-binding protein 3 from Pseudomonas aeruginosa: comparison of native and antibiotic-bound forms.
J Mol Biol. 2011 Jan 7;405(1):173-84. doi: 10.1016/j.jmb.2010.10.024. Epub 2010 Oct 23.
3
Beta-lactam antibiotics: from antibiosis to resistance and bacteriology.
APMIS. 2010 Jan;118(1):1-36. doi: 10.1111/j.1600-0463.2009.02563.x.
4
Increased Resistance of Pseudomonas aeruginosa to Carbenicillin After Reversion from Spheroplast to Rod Form.
Infect Immun. 1970 May;1(5):427-30. doi: 10.1128/iai.1.5.427-430.1970.
5
Human pharmacology of 6-[D-alpha-(3-guanylureido)-phenylacetamido]-penicillanic acid (BL-P1654).
Antimicrob Agents Chemother. 1974 Apr;5(4):366-70. doi: 10.1128/AAC.5.4.366.
6
Comparative in vitro evaluation of BL-P1654 and carbenicillin against Pseudomonas.
Antimicrob Agents Chemother. 1974 Nov;6(5):643-6. doi: 10.1128/AAC.6.5.643.
7
CI-867, a new semisynthetic penicillin: in vitro studies.
Antimicrob Agents Chemother. 1980 Dec;18(6):939-43. doi: 10.1128/AAC.18.6.939.
8
Susceptibility of Pseudomonas aeruginosa to carbenicillin.
Appl Microbiol. 1970 Oct;20(4):630-2. doi: 10.1128/am.20.4.630-632.1970.
9
Carbenicillin and gentamicin in the treatment of Pseudomonas aeruginosa infection.
Can Med Assoc J. 1971 Nov;105(9):919-22.
10
Specific therapy of Pseudomonas aeruginosa infection.
Can Med Assoc J. 1971 Nov;105(9):898-9.
Zotero 插件